NEW YORK, Sept 18 – Bioinformatics company Informax of Rockville, Md., said Monday it had released version 3.0 of Genomax, a software package that includes modules for sequence analysis, gene expression analysis, and 3-dimensional protein structure.
The software, which is geared to help pharmaceutical and biotechnology companies to integrate vast amounts of data, is designed for a multi-user environment. The software employs Oracle relational databases as well as a Java-based graphical user interface.
Genomax users include DuPont, Genzyme, Pioneer Hi-Bred, the University of Tokyo, and Massachusetts Institute of Technology.
The company said it is currently working on integrating new modules into Genomax, including genomic viewing, protein-protein interaction, and SNP analysis.
Informax’s other main product is Vector NTI, a desktop application used for sequence analysis and visualization.
The company reported revenues of $3.2 million in first-quarter 2000, up from $1.6 million in the year ago period. Software sales accounted for $2.4 million of this year’s first-quarter sales.
The company is planning to raise $75 million in an initial public offering on the Nasdaq within the next month.